Related Experiment Video
Updated: Jul 11, 2026
07:46
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid
Paola Mancino1, Claudio Ucciferri, Katia Falasca
1Clinic of Infectious Diseases, Centre of Excellence on Ageing, University 'G. d'Annunzio' School of Medicine, Chieti-Pescara, Italy.
Scandinavian Journal of Infectious Diseases
|September 14, 2007
Summary
Linezolid is a crucial treatment for infective endocarditis caused by multidrug-resistant organisms when standard therapies fail. This study reviews one patient and 45 literature cases, highlighting its necessity.
Area of Science:
- Infectious Diseases
- Pharmacology
- Cardiology
Background:
- Infective endocarditis (IE) poses significant treatment challenges, particularly with multidrug-resistant (MDR) pathogens.
- Standard antibiotic therapies for IE are often ineffective against MDR strains.
- Linezolid, an oxazolidinone antibiotic, presents a potential therapeutic option for refractory IE.
Observation:
- This report details a case of infective endocarditis successfully treated with linezolid.
- A comprehensive literature review identified 45 additional cases of IE managed with linezolid.
- The patient cases encompass various IE etiologies and patient profiles.
Findings:
- Linezolid demonstrated efficacy in treating infective endocarditis, especially in cases involving multidrug-resistant microorganisms.
- Treatment with linezolid was often a last resort when conventional therapies were unsuccessful.
- Clinical outcomes suggest linezolid can be a viable option for complex IE cases.
Implications:
- Linezolid should be considered a valuable therapeutic agent for infective endocarditis caused by multidrug-resistant bacteria.
- Further research is warranted to establish linezolid's role in standard infective endocarditis treatment guidelines.
- These findings support the expanded use of linezolid in challenging infectious endocarditis scenarios.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:18Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
01:25Endocarditis I: Introduction
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
01:29Endocarditis IV: Nursing Management
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...